Summary
The clinical onset of insulin-dependent diabetes is associated with several autoimmune phenomena including islet cell antibodies, glutamic acid decarboxylase (the GAD65 isoform) autoantibodies (GAD65Ab) as well as insulin autoantibodies. The molecular cloning of these autoantigens has permitted the development of precise and reproducible antibody immunoassays to identify marker-positive patients and control subjects. Among patients with new-onset diabetes about 70% were GAD65Ab positive compared to 1.5% among control subjects while 46% of patients had IAA compared to 1% among control subjects. The autoreactive sites or epitopes of GAD65 and insulin remain to be determined. The disease association with HLA on chromosome 6 may help to define the epitope specificity of the autoimmune reaction. Recent data suggest that 95% of new-onset IDDM children (0–15 years of age) are positive for either DQ2, DQ8 or both compared to about 50% of healthy control subjects. HLA-DQ6 is negatively associated with the disease. Both HLA-DQ2 and DQ8 therefore seem to be necessary, but not sufficent for diabetes. Molecular modelling suggests comparable physicochemical properties of DQ2 and DQ8 but are widely different from DQ6. In 1984, the conclusion was that molecular cloning of the genes for the autoantigens, antibodies, T-cell receptors, as well as HLA class I and II molecules associated with diabetes are essential for analysing the components which control the development of pancreatic beta-cell autoimmunity. In 1994, autoantigens and HLA molecules have been cloned and recombinant reagents developed to be used in experiments aimed at testing whether it will be possible to predict IDDM. Our understanding of immune autoreactivity is, however, still inadequate and remains a major challenge to future Minkowski Award hopefuls.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- RFLP:
-
Restriction fragment length polymorphism
- ICA:
-
islet cell antibodies
- IAA:
-
insulin autoantibodies
- kbp:
-
kilobase pair
- GAD:
-
glutamic acid decarboxylase
References
Lernmark Å (1985) Molecular biology of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 195–203
LaPorte RE, Tajima N, Åkerblom HK et al. (1985) Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 8: 101–107
Dahlquist G, Blom L, Holmgren G et al. (1985) The epidemiology of diabetes in Swedish children 0–14 years old, a six-year prospective study. Diabetologia 28: 802–808
Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S (1989) The Swedish childhood diabetes study — results from a 9 year case register and 1 year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32: 2–6
Nyström L, Dahlquist G, Rewers M, Wall S (1990) The Swedish childhood diabetes study: an analysis of the temporal variation in diabetes incidence 1978–1987. Int J Epidemiol 19: 141–146
Dahlquist G, Blom L, Lönnberg G (1991) The Swedish Childhood Diabetes Study — a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 34: 757–762
Tuomilehto J, Rewers M, Reunanen A et al. (1991) Increasing trend in type 1 (insulin-dependent) diabetes mellitus in childhood in Finland. Diabetologia 34: 282–287
Nyström L, Dahlquist G, Östman J et al. (1992) Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: Indications of climatological determinants for age at onset. Int J Epidemiol 21: 352–358
Owerbach D, Lernmark Å, Platz P et al. (1983) HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817
Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Lernmark Å (1993) Analysis of DRB1, DRB5, DQA1 and DQB1 genes in DR2 positive patients with type 1 diabetes. Diabetologia 36: A17 (Abstract)
Michelsen B, Lernmark Å (1987) Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152
Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT (1986) Specific genomic markers for the HLA-DQ subregion discriminate between DR4 + insulin-dependent diabetes mellitus and DR4 + seropositive juvenile rheumatoid arthritis. J Exp Med 164: 345–350
Todd JA, Bell JI, McDevitt HO (1987) HLA DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604
Wassmuth R, Lernmark Å (1989) The genetics of susceptibility to diabetes. Clin Immunol Immunopathol 53: 358–399
Michelsen B, Wassmuth R, Ludvigsson J, Lernmark Å, Nepom GT, Fisher L (1990) HLA heterozygosity in insulin-dependent diabetes is most frequent at the DQ locus. Scand J Immunol 31: 405–413
Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å (1993) HLA-DQ protection and HLA-DR susceptibility in type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Human Genet 42: 150–167
Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322: 1836–1882
Bodmer SG, March E, Parham P et al. (1990) Nomeclature for factors of the HLA system, 1989. Immunol Today 11: 3–10
Yamagata K, Nakajim H, Hanafusa T et al. (1989) Aspartic acid in position 57 of DQβ chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32: 762–764
Khalil I, DÁuriol L, Gobet M et al. (1990) A combination of HLA-DQβ Asp57-negative and HLA-DQalpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85: 1315–1319
Gyllensten UB, Erlich HA (1988) Generation of singlestranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85: 7652–7656
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of human class I histocompatibility antigen, HLA-A2. Nature 329: 506–512
Brown JH, Jardetsky TS, Gorga JC et al. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39
Thorsby E, Rønningen KS (1993) Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 371–377
Svejgaard A, Platz P, Ryder LP (1981) Insulin dependent diabetes mellitus. In: Terasaki PI (ed) Histocompatibility Testing 1980. Los Angeles: Tissue Typing Laboratory: UCLA PA 638–656
Nepom BS, Schwarz D, Palmer JP, Nepom GT (1987) Transcomplementation of HLA genes in IDDM: HLA-DQ — and α β-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes 36: 114–117
Sanjeevi CB, Olerup O (1992) Restriction fragment length polymorphism analysis of HLA-DRB, DQA and DQB genes in South Indians and Swedish Caucasians. Transplant Proc 24: 1687–1688
Sanjeevi CB, Zeidler A, Shaw S et al. (1993) Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus. Tissue Antigens 42: 72–77
Dahlquist G (1991) Epidemiological and ethical considerations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 536 (Letter)
Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway CA (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622–668
Singal DP, Blajchman MA (1973) Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22: 429–432
Nerup J, Platz P, Anderssen OO (1974) HL-A antigens and diabetes mellitus. Lancet II: 864–866
Farid NR, Sampson L, Noel P, Barnard JM, Davis AJ, Hillman DA (1979) HLA-D-related (DRw) antigens in juvenile diabetes mellitus. Diabetes 28: 552–557
Platz P, Jakobsen BK, Morling M et al. (1981) HLA-D and DR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
Lernmark Å, Baekkeskov S (1981) Islet cell antibodies-theoretical and practical implications. Diabetologia 212: 431–435
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169
Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322: 1555–1560
Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Martino G, Tappaz M, Braghi S et al. (1991) Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immunotrapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. J Autoimmunity 4: 915–923
Thivolet C, Beaufrére B, Geburher L, Chatelain P, Orgiazzi J, Francois R (1991) Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 34: 186–191
Erdö SL, Wolff JR (1990) Gamma-aminobutyric acid outside the mammalian brain. J Neurochem 54: 363–372
Briel G, Gylfe E, Hellman B, Neuhoff V (1972) Microdetermination of free amino acids in pancreatic islets isolated from obese-hyperglycemic mice. Acta Physiol Scand 84: 247–253
Sparkes RS, Kaufman DL, Heinzmann C, Tobin AJ, Mohandas T (1987) Brain glutamate decarboxylase (GAD) gene assigned to human chromosome 2 by somatic cell hybrid analysis. Cytogenet Cell Genet 46: 696
Julien J-F, Legay F, Dumas S, Tappaz M, Mallet J (1987) Molecular cloning, expression and in situ hybridization of rat brain glutamic acid decarboxylase messenger RNA. Neurosci Lett 73: 173–180
Kobayashi Y, Kaufman DL, Tobin AJ (1987) Glutamic acid decarboxylase cDNA: nucleotide sequence encoding as enzymatically active fusion protein. J Neurosci 7: 2768–2772
Katarova Z, Szabo G, Mugnaini E, Greenspan RJ (1990) Molecular identification of the 62 kd form of glutamic acid decarboxylase from the mouse. European J Neurosci 2: 190–202
Karlsen AE, Hagopian WA, Grubin CE et al. (1991) Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci US 88: 8337–8341
Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylase. Neuron 7: 91–100
Bu D-F, Erlander MG, Hitz BC et al. (1992) Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci 89: 2115–2119
Michelsen BK, Petersen JS, Boel E, Møldrup A, Dyrberg T, Madsen OD (1991) Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent mellitus. Proc Natl Acad Sci USA 88: 8754–8758
Karlsen AE, Hagopian WA, Petersen JS et al. (1992) Recombinant glutamic acid decarboxylase representing a single isoform expressed in human islets detects IDDM association 64 K autoantibodies. Diabetes 41: 1355–1359
Petersen JB, Russel S, Marshall MO et al. (1993) Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42: 484–495
Kaufman DJ, Erlander MG, Clare-Salzer M, Atkinson MA, Maclaren NK, Tobin AJ (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89: 283–292
Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA (1993) Demonstration of GAD-65 as the main immunogenic isoform of glutamate decaboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 91: 2084–2090
Hagopian WA, Karlsen AE, Gottsater A et al. (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64 K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91: 368–374
Grubin C, Daniels T, Toivola B et al. (1994) Isoform-specific recombinant glutamic acid decarboxylase antibodies in childhood insulin-dependent diabetes mellitus. Diabetologia 37: 344–350
Hagopian WA, Michelsen B, Karlsen AE et al. (1993) Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42: 631–636
Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR (1993) Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359–362
Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmer P (1992) Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 996–1001
Landin-Olsson M, Palmer JP, Lernmark Å et al. (1992) Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly diagnosed diabetic and matched control children. Diabetologia 35: 2068–1073
Palmer JP, Asplin CM, Demons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Falorni A, Takei I, Shimada A et al. (1993) Radioimmunoassay detects high frequency glutamate decarboxylase antibodies in Japanese diabetic patients. Diabetologia 36: A45 (Abstract)
Gorsuch AN, Spencer KM, Lister J et al. (1981) Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet II, 1363–1365
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 462–464
Riley WJ, Maclaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167–1172
Bärmeier H, McCulloch DK, Neifing JL et al. (1991) Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64 K antibodies. Diabetologia 34: 727–733
Tillil H, Köbberling J (1987) Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36: 93–99
Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794
Christie MR, Hollands JA, Brown TJ, Michelsen BM, Delovitch TL (1993) Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 92: 240–248
Christie MR, Tun RYM, Lo SSS et al. (1992) Antibodies to GAD and tryptic fragments of islet 64 K antigen as distinct markers for development of IDDM. Diabetes 41: 782–787
Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G (1989) Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 32: 387–395
Bingley PJ, Gale EAM (1989) Rising incidence of IDDM in Europe. Diabetes Care 12: 289–295
Levy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P (1992) Islet cell antibodies in normal French school-children. Diabetologia 35: 577–582
Scherbaum WA, Seißler J, Hedderich U, Boehm BO, Specker M, Pfeiffer EF (1989) Determination of islet cell antibodies using an ELISA system with a preparation of rat insulinoma (RIN A2) cells. Diabetes Res 10: 97–102
Hagopian W, Sanjeevi C, Landin-Olsson M et al. (1993) Relationship of glutamate decarboxylase antibodies (GAD65Ab) to ICA, IAA and HLA in a populationbased study of diabetic children. Diabetes 42 (Suppl. 1) 114A (Abstract)
McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Nonprogression of subclinical β-cell dysfunction among first degree relatives of IDDM patients: 5-yr follow-up of the Seattle family study. Diabetes 39: 549–556
Stiller CR, Dupré J, Gent M et al. (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223: 1362–1367
The Canadian-European Randomized Control Trial Group (1988) Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion. Diabetes 37: 1574–1582
Bougneres PF, Carel JC, Castano L et al. (1988) Factors associated with early remission of type 1 diabetes in children treated with cyclosporine. N Engl J Med 318: 6663–6670
Klintmalm G, Bohman S-O, Sudelin B, Wilczek H (1984) Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet 2: 950–954
Feutren G, Mihatsch MJ (1992) Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326: 1654–1660
Skyler JS, Marks JB (1993) Immune intervention in type 1 diabetes mellitus. Diabetes Reviews 1: 15–42
Jobe LW, Lernmark Å (1993) Detection of glutamic acid decarboxylase autoantibodies in streptozocin treated baboons. Clin Res 41: 41A (Abstract)
Atkinson MA, Kaufman DL, Campbell L et al. (1992) Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458–459
Harrison LC, Honeyman MC, Deaizpurua HJ et al. (1993) Inverse regulation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365–1369
Karjalainen J, Martin JM, Knip M et al. (1992) A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327: 302–307
Pietropaolo M, Castano L, Babu S et al. (1993) Islet cell autoantigen 69KDa (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92: 359–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lernmark, Å. Molecular biology of IDDM. Diabetologia 37 (Suppl 2), S73–S81 (1994). https://doi.org/10.1007/BF00400829
Issue Date:
DOI: https://doi.org/10.1007/BF00400829